- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01806831
Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
March 10, 2015 updated by: Pornanong Aramwit, Pharm.D., Ph.D, Chulalongkorn University
Efficacy and Safety of Biocellulose Sheet From Coconut Juice Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
The laser areas treated with biocellulose sheet from coconut juice containing anti-hyperpigmentation agent ("biocellulose mask", "Farhorm®") heal faster than vaseline ointment which is a standard treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Volar surface at upper arm (2X2 cm) on both sides were treated with semi ablative, 1,550 nm Erbium: glass fractional laser.
Biocellulose sheet from coconut juice containing anti-hyperpigmentation agent ("biocellulose mask","Farhorm®")was applied for 20 min on one side and the other side was treated with vaseline ointment.
The redness, skin hydration and skin pigmentation were evaluated at that area before laser, immediately after laser and after applying the treatment.
These parameters were compared between treatment (area treated with Biocellulose sheet from coconut juice containing anti-hyperpigmentation agent, "biocellulose mask", "Farhorm®") and control (vaseline ointment).
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10310
- Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 20-50 years old
- No skin problem such as inflammation, fresh wounds
- Not receive laser treatment during last 3 months
- No history of smoking or alcohol drinking
- No allergy to licorice extract, Vit C, Vit E, arbutin or stearyl glycyrrhetinate
- Willing to participate in this study and can comply with study protocol
Exclusion Criteria:
- Has history of hyperallergic reaction
- Has wound(s) on face during last 4 weeks
- Has history of eczema, psoriasis during last 6 months
- Has laser treatment during last month
- Use steroid, antibiotic, anti-inflammatory drugs or antihistamine during 3 days before recruiting
- Had major surgery during last 12 months
- Has history of cancer during last 12 months
- Pregnant or lactation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The skin pigmentation immediately after laser therapy and after using biocellulose mask
Time Frame: Change from immediately after laser treatment and 30 min after laser and treatment with mask
|
Change from immediately after laser treatment and 30 min after laser and treatment with mask
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
March 5, 2013
First Submitted That Met QC Criteria
March 6, 2013
First Posted (Estimate)
March 7, 2013
Study Record Updates
Last Update Posted (Estimate)
March 11, 2015
Last Update Submitted That Met QC Criteria
March 10, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CU 12-33-009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Irritation
-
Galderma R&DCompleted
-
University Hospitals Cleveland Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
Ventrus Biosciences, IncUnknownSkin IrritationUnited States
-
Repolar Pharmaceuticals OyPrinceton Consumer ResearchCompletedSkin Sensitization | Skin IrritationUnited Kingdom
-
Galderma R&DCompletedSkin IrritationUnited States
-
Corium, Inc.CompletedSkin Irritation | SensitizationUnited States
-
Galderma R&DCompletedSkin IrritationUnited States
-
Mother's Choice LtdUnknownSkin Irritation | Hand HygieneIsrael
-
Sheri Kashmir Institute of Medical SciencesCompletedCough | Irritation in Throat | Irritation in Skin | LacrimationIndia
-
Galderma R&DCompletedSkin IrritationUnited States
Clinical Trials on "Biocellulose Mask", Farhorm®"
-
Siperstein DermatologyCompleted
-
He Eye HospitalNot yet recruiting
-
Revision SkincareTone DermatologyCompletedSkin Smoothness | Radiance | Overall AppearanceUnited States
-
AlyatecMedicomCompletedAllergic Rhinitis | Allergic AsthmaFrance
-
University of BirminghamBirmingham Community Healthcare NHSCompleted
-
Geneve TEAM AmbulancesUniversity Hospital, Geneva; ESAMB - College of Higher Education in Ambulance... and other collaboratorsCompletedCardiac Arrest | Pediatric ALL | Resuscitation | Cardiopulmonary Arrest | Pediatric Emergency MedicineSwitzerland
-
Geneve TEAM AmbulancesService de protection et sauvetage Lausanne (SPSL), Emergency Medical Services... and other collaboratorsCompletedCardiac Arrest | Emergency Medical Services | Resuscitation | Cardiopulmonary ArrestSwitzerland
-
University of KentKing's College Hospital NHS Trust; Royal Brompton & Harefield NHS Foundation... and other collaboratorsCompletedAsthma | Asthma, Exercise-Induced
-
Ankara City Hospital BilkentNot yet recruitingAirway Management | Shoulder Surgery | Supraglottic Airway | General AnestheticTurkey (Türkiye)
-
Universidade do Vale do SapucaiCompletedRespiration Disorders | Acid-Base ImbalanceBrazil